Cargando…

Decreasing microbiota-derived uremic toxins to improve CKD outcomes

Chronic kidney disease (CKD) is set to become the fifth-leading global cause of death by 2040. This illustrates the many unknowns regarding its pathogenesis and therapy. A key unknown relates to the therapeutic impact of the interaction between CKD and the gut microbiome. The normal gut microbiome i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beker, Braian M, Colombo, Iara, Gonzalez-Torres, Henry, Musso, Carlos G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664568/ https://www.ncbi.nlm.nih.gov/pubmed/36381370 http://dx.doi.org/10.1093/ckj/sfac154

Ejemplares similares

The Impact of CKD on Uremic Toxins and Gut Microbiota
por: Rysz, Jacek, et al.
Publicado: (2021)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice
por: Caggiano, Gianvito, et al.
Publicado: (2023)

Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD
por: Pieniazek, Anna, et al.
Publicado: (2021)

Gut Microbiota Dynamics and Uremic Toxins
por: Mishima, Eikan, et al.
Publicado: (2022)

Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
por: Chen, Jia-Huang, et al.
Publicado: (2021)

Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization
por: Filipska, Iwona, et al.
Publicado: (2021)

Gut Microbiota as a Source of Uremic Toxins
por: Popkov, Vasily A., et al.
Publicado: (2022)

Uremic Toxin-Producing Bacteroides Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baseline
por: Shivani, Subhashree, et al.
Publicado: (2022)

Gut-Derived Protein-Bound Uremic Toxins
por: Graboski, Amanda L., et al.
Publicado: (2020)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Food-Derived Uremic Toxins in Chronic Kidney Disease
por: Lauriola, Mara, et al.
Publicado: (2023)

Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression
por: Takada, T., et al.
Publicado: (2018)

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
por: Liabeuf, Sophie, et al.
Publicado: (2018)

Uremic Toxins and Vascular Dysfunction
por: Six, Isabelle, et al.
Publicado: (2020)

Uremic Toxins in Organ Crosstalk
por: Lowenstein, Jerome, et al.
Publicado: (2021)

Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease
por: Addi, Tawfik, et al.
Publicado: (2018)

Derivation and elimination of uremic toxins from kidney-gut axis
por: Xu, Ying, et al.
Publicado: (2023)

Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
por: Pan, Libin, et al.
Publicado: (2023)

Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production
por: Wang, Yingyi, et al.
Publicado: (2020)

Interaction of Human Serum Albumin with Uremic Toxins: The Need of New Strategies Aiming at Uremic Toxins Removal
por: Zare, Fahimeh, et al.
Publicado: (2022)

Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins
por: Chao, Chia-Ter, et al.
Publicado: (2020)

Uremic Apelin and Leucocytic Angiotensin-Converting Enzyme 2 in CKD Patients
por: Trojanowicz, Bogusz, et al.
Publicado: (2020)

Uremic Toxin Clearance and Cardiovascular Toxicities
por: Mair, Robert D., et al.
Publicado: (2018)

Parathyroid Hormone: A Uremic Toxin
por: Duque, Eduardo J., et al.
Publicado: (2020)

Enzobiotics—A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial
por: Saxena, Anita, et al.
Publicado: (2022)

Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients
por: Paats, Joosep, et al.
Publicado: (2020)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System
por: Falconi, Carlos Alexandre, et al.
Publicado: (2021)

Effects of the uremic toxin indoxyl sulphate on human microvascular endothelial cells
por: Colombo, Graziano, et al.
Publicado: (2022)

Phosphate, Microbiota and CKD
por: Favero, Chiara, et al.
Publicado: (2021)

The Association of Uremic Toxins and Inflammation in Hemodialysis Patients
por: Hsu, Heng-Jung, et al.
Publicado: (2014)

Hemolytic Uremic Syndrome: Toxins, Vessels, and Inflammation
por: Cheung, Victoria, et al.
Publicado: (2014)

The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders
por: Assem, Maryam, et al.
Publicado: (2018)

How do Uremic Toxins Affect the Endothelium?
por: da Cunha, Regiane Stafim, et al.
Publicado: (2020)

Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2021)

Improved cardiovascular autonomic function and decreased protein-bound uremic toxins in patients with end-stage renal disease after peritoneal dialysis
por: Cheng, Ben-Chung, et al.
Publicado: (2020)

Acute Kidney Injury and Organ Dysfunction: What Is the Role of Uremic Toxins?
por: Lara-Prado, Jesús Iván, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Reducing Uremic Toxins Accumulation in Kidney Disease: Current Understanding and Future Perspectives
por: Caggiano, Gianvito, et al.
Publicado: (2023)

Role of gut microbiota‐derived metabolites on vascular calcification in CKD
por: Yin, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vf67tqd3u7etpao1sfdckr2vbm